Overview

The Pharmacokinetic Study of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin Ca

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the comparative pharmacokinetics and safety of fixed-dose combination versus coadministration of Lipilfen cap.160mg(micronized fenofibrate160mg) and Livalo tab. 2mg(pitavastatin Ca 2mg) under fed condition in healthy male volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Hanlim Pharm. Co., Ltd.
Treatments:
Fenofibrate
Pitavastatin